Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: News & Announcements 2018

Top 20 Shareholders 30th December 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAustJanuary 7, 2019

December Top_Holder_-_Detail_-_Single_Date

Top 20 Shareholders 14 December 2018

News & Announcements 2018By Richard MollardDecember 17, 2018

Top_Holders_Report (14)Download

PharmAust Manufacturing Method Maintains Drug Potency

News & Announcements 2018By Richard MollardDecember 2, 2018

440ws7dgb0lrfl

GMP Tablet Production for Clinical Trials Commences

News & Announcements 2018By Richard MollardNovember 13, 2018

181113_GMP Tablet Manufacture_44070bgt7qng63

2018 AGM Results

News & Announcements 2018By Richard MollardNovember 9, 2018

2018 AGM Results

2018 AGM Presentation

News & Announcements 2018By Richard MollardNovember 9, 2018

2018 AGM Presentation

Top 20 Shareholders 31st October 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAustNovember 6, 2018

Top_Holder_-_Detail_-_Single_Date October

Drug Reformulation Play With Significant Potential

News & Announcements 2018, Research Notes 2018By PharmAustNovember 6, 2018

2018 11 05 PharmAust report from NDF Research This report has been commissioned and paid for by PharmAust (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of Pitt Street Research. Any opinions, forecasts, recommendations or forward-looking statements in the report…

September 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2018, News & Announcements 2018By Richard MollardNovember 1, 2018

43zxgv0spl3ht0

GMP Method for PharmAust Analogue Pipeline

News & Announcements 2018By Richard MollardOctober 29, 2018

181029_GMP_AAD_Manufacture

12345
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on TwitterPharmAust Retweeted
epichemEpichem@epichem·
29 Jun

𝐖𝐄𝐋𝐂𝐎𝐌𝐄 Fiona Milner!

Today we are rolling out the red carpet as Fiona Milner joins Epichem Pty Ltd as General Manager. The Epichem team are thrilled to have Fiona on board and we look forward to working with her.

#teamepichem

Reply on Twitter 1541992242344333312Retweet on Twitter 15419922423443333121Like on Twitter 15419922423443333125Twitter 1541992242344333312
Load More...
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top